Personal data protection

• Strategy of “compliance” for the processing of companies’ personal data
• Management of personal data processing operations in the information technologies and e-commerce sectors
• Design and implementation of a regulatory strategy for processing personal data (particularly sensitive data)

Cosmetics, dietary supplements, medical devices

• Product qualification
• Clinical trials: contractual relations with investigators, clinical trial contracts and good practices, informed consent
• Relations with supervisory authorities (French Health Products Safety Agency (AFSSAPS), French Food Safety Agency (AFSSA), General Directorate for Competition Policy, Consumer Affairs and Fraud Control (DGCCRG) and LNE-GMed)
• Labelling, CE marking, presentation, advertising
• Commercial litigation, liability litigation, criminal litigation (illegal practice of pharmacy, misleading commercial practices and falsification)
• EU litigation (monopoly of pharmacists and free movement of goods)
• Lobbying in the context of transposition of EU legislation into domestic law

Human reproductive materials

• Regulations governing collection, storage, preparation and use
• Negotiation of private and public-private partnerships (pharmaceutical laboratories, hospitals and institutions)
• Lobbying the legislator
• Relations with supervisory authorities (French Health Products Safety Agency (AFSSAPS), French Biomedicine Agency (Agence de la Biomédecine) and French National Blood Service (EFS))

Drugs

• Procurement, disposal and acquisition of marketing authorisations
• Advertising aimed at the public and healthcare professionals
• Manufacturing activity (raw materials, pharmaceutical establishments, head/acting pharmacist, shaping)
• Wholesale and retail distribution